Skip to Content

DA-033 20 (Abilify MyCite 20 mg)

Generic Name: aripiprazole

Pill with imprint DA-033 20 is White, Round and has been identified as Abilify MyCite 20 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-033 20

Abilify mycite 20 mg DA-033 20

Abilify MyCite

Generic Name
aripiprazole
Imprint
DA-033 20
Strength
20 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Atypical antipsychotics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Otsuka Pharmaceutical Co., Ltd
National Drug Code (NDC)
59148-0033
Inactive Ingredients
corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, ferric oxide yellow, ferric oxide red, FD&C Blue No. 2, aluminum oxide, aluminum, magnesium, silicon, silicon dioxide, titanium, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.